Gunter von Minckwitz, MD: Early Survival Analysis of GeparSixto
2015 San Antonio Breast Cancer SymposiumGunter von Minckwitz, MD, of the German Breast Group, discusses data from this phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative and HER2-positive early breast cancer (Abstract S2-05).